PYXS
PYXS
NASDAQ · Biotechnology

Pyxis Oncology Inc

$1.51
-0.03 (-1.95%)
As of Feb 8, 2:12 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 59.72M 61.79M 57.95M
Net Income -17,457,928 -16,293,891 -13,275,510
EPS
Profit Margin -29.2% -26.4% -22.9%
Rev Growth -4.4% +5.4% +21.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.30M 10.88M 8.95M
Total Equity 30.51M 34.64M 32.57M
D/E Ratio 0.30 0.31 0.27
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -19,228,267 -21,164,861 -19,065,899
Free Cash Flow -18,637,383 -17,592,445 -15,576,212